ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Parnell Pharmaceuticals
1.00
0.0000
成交量:
- -
成交額:
- -
市值:
1,328.37萬
市盈率:
-1.30
高:
1.00
開:
1.00
低:
1.00
收:
1.00
52周最高:
3.95
52周最低:
0.6500
股本:
1,328.37萬
流通股本:
667.00萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-0.7700
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字:
Parnell Pharmaceuticals
交易所:
NASDAQ
成立時間:
- -
員工人數:
- -
公司地址:
- -
官網:
http://www.parnell.com
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Parnell Pharmaceuticals Holdings Ltd於2009年6月25日在澳大利亞註冊成立為一個專有的股份有限公司,在2009年7月10日企業發生重組作為公司的一部分。該公司是一個完全集成的製藥公司,致力於開發,製造和商業化創新的動物保健解決方案。公司目前市場對動物及生產動物的五大產品,在14個國家和增加公司的專有域和mysynch軟件平台的醫藥產品。這些創新的技術解決方案的目的是提高動物的生活質量或性能,而驅動客戶的運營效率和盈利能力。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PARN/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"PARN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PARN\",,,,,undefined,":{"symbol":"PARN","market":"US","secType":"STK","nameCN":"Parnell Pharmaceuticals","latestPrice":1,"timestamp":1483650000000,"preClose":1,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":6670000,"shares":13283722,"eps":-0.77,"marketStatus":"退市","change":0,"latestTime":"01-05 16:00:00 EST","open":1,"high":1,"low":1,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.77,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774512000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1403064000000,"exchange":"NASDAQ","adjPreClose":1,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PARN\",,,,,undefined,":{"symbol":"PARN","floatShares":6670000,"roa":"--","roe":"--","lyrEps":0,"shares":13283722,"dividePrice":0,"high":1,"amplitude":0,"preClose":1,"low":1,"week52Low":0.65,"pbRate":"--","week52High":3.95,"institutionHeld":0,"latestPrice":1,"eps":-0.77,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.77,"open":1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PARN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-11-02","symbol":"PARN","fiscalQuarterEnding":null,"expectedEps":-0.06,"name":null,"time":"盤後","type":"earning","dateTimestamp":1478059200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-08-04","symbol":"PARN","fiscalQuarterEnding":null,"expectedEps":-0.54,"name":null,"time":"盤前","type":"earning","dateTimestamp":1470283200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-04-22","symbol":"PARN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1461297600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-02-24","symbol":"PARN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1456290000000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2015-10-21","symbol":"PARN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1445400000000,"reportTimeType":"pre","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PARN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PARN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.parnell.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0375},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0076},{"period":"1year","weight":0.1414},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Parnell Pharmaceuticals Holdings Ltd於2009年6月25日在澳大利亞註冊成立為一個專有的股份有限公司,在2009年7月10日企業發生重組作為公司的一部分。該公司是一個完全集成的製藥公司,致力於開發,製造和商業化創新的動物保健解決方案。公司目前市場對動物及生產動物的五大產品,在14個國家和增加公司的專有域和mysynch軟件平台的醫藥產品。這些創新的技術解決方案的目的是提高動物的生活質量或性能,而驅動客戶的運營效率和盈利能力。","exchange":"NASDAQ","name":"Parnell Pharmaceuticals","nameEN":"Parnell Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PARN\",market:\"US\",,,undefined,":null}}